All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378041%3A_____%2F23%3A00580704" target="_blank" >RIV/68378041:_____/23:00580704 - isvavai.cz</a>

  • Alternative codes found

    RIV/00098892:_____/23:10157303 RIV/75010330:_____/23:00014468 RIV/00216208:11140/23:10453381 RIV/00216208:11110/23:10453381 RIV/61989592:15110/23:73614836

  • Result on the web

    <a href="https://onlinelibrary.wiley.com/doi/10.1002/ijc.34383" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1002/ijc.34383</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/ijc.34383" target="_blank" >10.1002/ijc.34383</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk

  • Original language description

    Genes carrying high-penetrance germline mutations may also be associated with cancer susceptibility through common low-penetrance genetic variants. To increase the knowledge on genetic pancreatic ductal adenocarcinoma (PDAC) aetiology, the common genetic variability of PDAC familial genes was analysed in our study. We conducted a multiphase study analysing 7745 single nucleotide polymorphisms (SNPs) from 29 genes reported to harbour a high-penetrance PDAC-associated mutation in at least one published study. To assess the effect of the SNPs on PDAC risk, a total of 14 666 PDAC cases and 221 897 controls across five different studies were analysed. The T allele of the rs1412832 polymorphism, that is situated in the CDKN2B-AS1/ANRIL, showed a genome-wide significant association with increased risk of developing PDAC (OR = 1.11, 95% CI = 1.07-1.15, P = 5.25 x 10(-9)). CDKN2B-AS1/ANRIL is a long noncoding RNA, situated in 9p21.3, and regulates many target genes, among which CDKN2A (p16) that frequently shows deleterious somatic and germline mutations and deregulation in PDAC. Our results strongly support the role of the genetic variability of the 9p21.3 region in PDAC aetiopathogenesis and highlight the importance of secondary analysis as a tool for discovering new risk loci in complex human diseases.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30101 - Human genetics

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    International Journal of Cancer

  • ISSN

    0020-7136

  • e-ISSN

    1097-0215

  • Volume of the periodical

    153

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    7

  • Pages from-to

    373-379

  • UT code for WoS article

    000900470100001

  • EID of the result in the Scopus database

    2-s2.0-85144134666